Table 2 Antimicrobial resistance profiles of E. coli and Klebsiella pneumoniae in the three districts
Antimicrobial | Districts | p value (variation across the districts) | |||
|---|---|---|---|---|---|
Kampala n/N (%) | Kayunga n/N (%) | Mpigi n/N (%) | Total n/N (%) | ||
Ampicillina | 224/258 (86.8) | 218/396 (55.1) | 175/275 (63.9) | 617/928 (66.5) | <0.001 |
Amoxicillin-clavulanate | 184/274 (67.2) | 80/406 (19.7) | 88/304 (29.0) | 352/984 (35.8) | <0.001 |
Cefuroxime | 43/273 (15.8) | 77/405 (19.0) | 22/304 (7.2) | 142/982 (14.5) | <0.001 |
Ceftriaxone | 16/274 (5.8) | 2/406 (0.5) | 10/303 (3.3) | 28/983 (2.9) | <0.001 |
Cefotaxime | 14/273 (5.1) | 2/406 (0.5) | 6/302 (2.0) | 22/981 (2.2) | <0.001 |
Ceftazidime | 15/273 (5.5) | 2/406 (0.5) | 8/304 (2.6) | 25/983 (2.5) | <0.001 |
Cefepimeb | 93/178 (52.3) | 26/76 (34.2) | 29/91 (31.9) | 148/345 (42.9) | 0.001 |
Ciprofloxacin | 73/274 (26.6) | 15/405 (3.7) | 17/304 (5.6) | 105/983 (10.7) | <0.001 |
Sulfamethoxazole-trimethoprim | 234/272 (86.0) | 262/405 (64.7) | 189/304 (62.2) | 685/981 (69.8) | <0.001 |
Gentamicin | 68/273 (24.9) | 19/406 (4.7) | 18/303 (5.9) | 105/982 (10.7) | <0.001 |
Nitrofurantoin | 23/270 (8.5) | 4/403 (1.0) | 8/304 (2.6) | 35/977 (3.6) | <0.001 |
Chloramphenicol | 83/273 (30.4) | 54/405 (13.3) | 56/301 (18.6) | 193/979 (19.7) | <0.001 |
Cefoxitinb | 106/181 (58.6) | 40/78 (51.3) | 63/88 (71.6) | 209/(60.2) | 0.023 |
Piperacillin-tazobactumb | 126/173 (72.8) | 64/79 (81.0) | 67/93 (72.0) | 257/345 (74.5) | 0.315 |
Meropenem | 0/273 (0.0) | 0/403 (0.0) | 0/300 (0.0) | 0/976 (0.0) | – |